La “guerra” es contra nuestras limitaciones conceptuales que el virus ha desnudado
DOI:
https://doi.org/10.37711/rpcs.2020.2.3.189Keywords:
war, limitations, Virus del SARSAbstract
The SARS-CoV-2 virus infection that has us in the midst of a pandemic that changed the course of humanity, not only affected and consumed the lives of many patients, but also took care of destroying and taking the lives of those responsible for defending it: medical, nursing and health personnel in general. When we trained in medical school, we did so out of conviction and always thinking of protecting the health and lives of others, but we never did so thinking of sacrificing our own lives. This pandemic has shown us that, despite the great advances in medicine, the era of antibiotics, molecular biology, the ability to create life in the laboratory, the billions of dollars spent on medical technology and the immense amount of ink used to publish articles in medical science journals, we are still not prepared to face a new virus that is invisible to the human eye, but which has already killed more people than the two atomic bombs of Hiroshima and Nagasaki.
Downloads
References
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis [Internet] 2020; 10(2): 102–8 [Consultado 2020 Sep 29] Disponible en: https://www.sciencedirect.com/science/article/pii/S2095177920302045
Chen J, Kelley WJ, Goldstein DR. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19. J Immunol [Internet] 2020 Jul 15; 205(2): 313-20 [Consultado 2020 Sep 29] Disponoble en: https://pubmed.ncbi.nlm.nih.gov/32493812/
Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. GeroScience. Springer [Internet] 2020 Apr; 42(2): 505–514 [Consultado 2020 Sep 29] Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145538/
Taubenberger JK, Morens DM. 1918 Influenza: the Mother of All Pandemics. Emerg Infect Dis [Internet] 2006 Jan; 12(1): 15–22 [Consultado 2020 Oct 1] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291398/
Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection. Springer [Internet] 2020 Sep 4 [Consultado 2020 Sep 30] Disponible en: https://doi.org/10.1007/s15010-020-01516-2
Sette A, Crotty S. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns. Nature Reviews Immunology [Internet] 2020 Aug; 20(8): 457-458 [Consultado 2020 Sep 29] doi: 10.1038/s41577-020-0389-z
Ministerio de Salud. Perú. Instructivo para la aplicación de las pruebas rápidas [Internet] [Consultado 2020 Sep 30] Disponible en: https://web.ins.gob.pe/es/salud-publica/como-hacer-prueba-rapida
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis [Internet] 2020 Mar 28 [Consultado 2020 Sep 29] Disponible en: https://pubmed.ncbi.nlm.nih.gov/32221519/
Chen Y, Tong X, Li Y, Gu B, Yan J, Liu Y, et al. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients. PLoS Pathog [Internet] 2020 Sep 1; 16(9): e1008796 [Consultado 2020 Sep 29] Disponible en: https://pubmed.ncbi.nlm.nih.gov/32913364/
Zhu M. SARS Immunity and Vaccination. Cellular & Molecular Immunology [Internet] 2004 Jun; 1(3): 193-198 [Consultado 2020 Sep 29] Disponible en: http://www.cmi.ustc.edu.cn/1/3/193.pdf
Kellam P, Barclay W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection The Journal of general virology NLM (Medline) [Internet] 2020; 101(8): 791-7 [Consultado 2020 Oct 1] Disponible en: https://www.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.001439
Niedzwiedz CL, O’Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: Prospective cohort study using UK Biobank. BMC Med [Internet] 2020 May 29; 18(1): 160 [Consultado 2020 Sep 29] doi: 10.1186/s12916-020-01640-8
Gandhi M, Rutherford GW. Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine. N Engl J Med [Internet] 2020 Sep 8 [Consultado 2020 Sep 29] doi: 10.1056/NEJMp2026913
Tomassini S, Kotecha D, Bird PW, Folwell A, Biju S, Tang JW. Setting the criteria for SARS-CoV-2 reinfection – six possible cases. Journal of Infection. W.B. Saunders Ltd [Internet] 2020 Aug 12; S0163-4453(20)30546-6 [Consultado 2020 Sep 29] doi: 10.1016/j.jinf.2020.08.011
Zeberg H, Pääbo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature [Internet] 2020 Sep 30 [Consultado 2020 Oct 1] Disponible en: http://www.nature.com/articles/s41586-020-2818-3
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med [Internet] 2020 Jun 17 [Consultado 2020 Oct 1] Disponible en: http://www.nejm.org/doi/10.1056/NEJMoa2020283
Soto-Becerra P, Culquichicón C, Hurtado-Roca Y, Araujo-Castillo R V. Real-World Effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: Results of a target trial emulation using observational data from a nationwide Healthcare System in Peru. medRxiv [Internet]. 2020 Oct 8 [Consultado 2020 Oct 9];2020.10.06.20208066. Disponible en: https://doi.org/10.1101/2020.10.06.20208066
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Heinner Guio, Raúl Ortega
This work is licensed under a Creative Commons Attribution 4.0 International License.
